Bridgebio Oncology Therapeutics, Inc. (BBOT)
1.81
-0.05
(-2.69%)
USD |
NASDAQ |
Nov 20, 16:00
1.815
0.00 (0.00%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Cash and Short Term Investments (Annual) : 425.46M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 425.46M |
| December 31, 2024 | 155.63M |
| December 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Korsana Biosciences, Inc. | 3.24M |
| IRulya Therapeutics, Inc. | 17.75M |
| PepGen Inc. | 148.46M |
| Q32 Bio, Inc. | 48.30M |
| Oncolytics Biotech, Inc. | 5.202M |